A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: Halifax, New Haven CT, Westbury NY, Columbia MD,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase3, Recruiting
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: New York NY, Houston TX, Duarte CA
Sponsor: Edgewood Oncology Inc.
Sex: All
Age: 18+
Code: NCT04243785
Phase1, Recruiting
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
for
Leukemia, High Risk Acute Lymphoblastic Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia
Sex: All
Age: 0 - 25
Code: NCT06839456
Phase1, Phase2, Recruiting
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
for
Severe Aplastic Anemia, Hypo-Plastic MDS,
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Sex: All
Age: 4 - 70+
Code: NCT03173937
Phase1, Phase2, Recruiting
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 12+
Code: NCT03383575
Phase2, Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase1, Recruiting
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome